About Ma VMVK Pharma Private Limited
Data last updated:
Ma VMVK Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 30 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2020PTC240178. Its GSTIN is 19AAHCV6329F1Z1 (West Bengal).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors Vipul Majeji and Vandana Majeji.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.69 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹11.57 Lakh (net margin 1.7%) and EBITDA of ₹35.12 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years.
As per MCA filings, the company has open charges of ₹2.67 Cr on record.
For more details, the company can be reached via its website procareimmuno.com.
Company details
Contact details
Ma VMVK Pharma Private Limited's registered office is in Kolkata, West Bengal. Its website is procareimmuno.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address4/1, Ashu Biswas Road, Kolkata, West Bengal, India – 700025
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Ma VMVK Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ma VMVK Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ma VMVK Pharma Private Limited, buy the company report.
Financials of Ma VMVK Pharma Private Limited
FY 2025 filings availableMa VMVK Pharma Private Limited reported revenue of ₹6.69 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over three years, including 16% growth in the latest year. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ma VMVK Pharma Private Limited, buy the company report.
Board of directors of Ma VMVK Pharma Private Limited
Ma VMVK Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vipul Majeji Also directs: VMVK Mercantile Private Limited | Director | 20 May 2021 | 5 Years 5 Months | Current |
| Vandana Majeji Also directs: VMVK Mercantile Private Limited | Director | 07 Dec 2022 | 3 Years 10 Months | Current |
Peer comparison
Ma VMVK Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wizcure Medical Devices Private Limited | ₹6.71 Cr (FY 2025) | -2.0% | Tijara, Rajasthan, India | |||
| Hiddenelements Private Limited | ₹6.71 Cr (FY 2025) | -42.0% | Bhopal, Madhya Pradesh, India | |||
| Sorbax Pharmaceuticals Private Limited | ₹6.71 Cr (FY 2025) | -16.0% | Baddi, Himachal Pradesh, India | |||
| Greenco Biologicals Pvt Ltd | ₹6.7 Cr (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Sanvita Biotechnologies Private Limited | ₹6.7 Cr (FY 2024) | -68.0% | Mallepally Village, Telangana, India | |||
| Ma VMVK Pharma Private Limitedthis company | ₹6.69 Cr (FY 2025) | ₹11.57 Lakh | 1.7% | 16.0% | Kolkata, West Bengal, India | |
| Leaf Cleantech Private Limited | ₹6.69 Cr (FY 2024) | 42.0% | Bangalore, Karnataka, India | |||
| Shrihari Mahalaxmi Industries Private Limited | ₹6.69 Cr (FY 2024) | 129.0% | Bareilly, Uttar Pradesh, India | |||
| DRSM Medikare Private Limited | ₹6.69 Cr (FY 2025) | 26.0% | Chandigarh, India | |||
| LN Solvents Private Limited | ₹6.69 Cr (FY 2025) | -15.0% | Bangalore, Karnataka, India | |||
| Modi Life Care Industries Limited | ₹6.68 Cr (FY 2025) | 49.0% | Odhav, Gujarat, India |
To see the full peer comparison of Ma VMVK Pharma Private Limited, buy the company report.
Auditor
Ma VMVK Pharma Private Limited is audited by GUJRANI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUJRANI & CO | FY 2022 | 322101E |
Shareholding
The shareholding of Ma VMVK Pharma Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ma VMVK Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Feb 2026 | 101239290 | Axis Bank Limited | ₹2 Cr | Open | |
| 08 Apr 2025 | 101101799 | Hdfc Bank Limited | ₹50 Lakh | Open | |
| 23 Feb 2023 | 100774613 | Hdfc Bank Limited | ₹17 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Ma VMVK Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ma VMVK Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ma VMVK Pharma Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Ma VMVK Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAHCV6329F1Z1 | West Bengal | Active | 01 Dec 2020 |
To see the full GST registrations and return filing status of Ma VMVK Pharma Private Limited, buy the company report.
Recent activity
Ma VMVK Pharma Private Limited has 7 board changes on record since 2020: 2 appointments and 5 cessations. The latest: Namrata Kathotia ceased to be Director on 07 Dec 2022.
1 earlier event is in the company report.
Frequently asked questions
Ma VMVK Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 30 September 2020 (6+ years old) and is registered under CIN U24100WB2020PTC240178.
Ma VMVK Pharma has 2 current directors:
- Vipul Majeji - Director
- Vandana Majeji - Director
The latest financial statements of Ma VMVK Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Ma VMVK Pharma is 19AAHCV6329F1Z1, registered in West Bengal.
The CIN (Corporate Identification Number) of Ma VMVK Pharma is U24100WB2020PTC240178. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ma VMVK Pharma was incorporated on 30 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Ma VMVK Pharma by revenue are Wizcure Medical Devices Private Limited, Hiddenelements Private Limited, Sorbax Pharmaceuticals Private Limited, Greenco Biologicals Pvt Ltd, Sanvita Biotechnologies Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Namrata Kathotia ceased to be Director on 07 Dec 2022. Swati Kathotia ceased to be Director on 07 Dec 2022. Vandana Majeji was appointed as Director on 07 Dec 2022. Ma VMVK Pharma has 7 board changes on record in total.
Ma VMVK Pharma can be reached through the website procareimmuno.com. Its registered office is in Kolkata, West Bengal, India.
The registered office of Ma VMVK Pharma is at 41, Ashu Biswas Road, Kolkata, West Bengal, India – 700025.
Ma VMVK Pharma operates in the chemicals and materials industry, in the industrial chemicals segment.